Drug Shortage Report for VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP
Report ID | 42315 |
Drug Identification Number | 02378345 |
Brand name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
Common or Proper name | VANCOMYCIN |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VANCOMYCIN |
Strength(s) | 10G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1x10g GVL |
ATC code | J01XA |
ATC description | OTHER ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-05-25 |
Estimated end date | |
Actual end date | 2019-07-29 |
Shortage status | Resolved |
Updated date | 2019-07-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-03-08 | English | Compare |